Search
for
Sort by
Research 361–390 of 1000+
- A Guide to Assessing Damage Response Pathways of the Hair Follicle: Lessons From Cyclophosphamide-Induced Alopecia in Mice
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Artificial Intelligence in Patient Education for Androgenetic Alopecia: A Comparative Study of ChatGPT, Gemini, and Deepseek R1
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Pharmacotherapy of alopecia areata
- PERSONAL EXPERIENCE OF MONOCHROMATIC EXCIMER PHOTOTHERAPY OF ALOPECIA AREATA
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Mice with Alopecia, Osteoporosis, and Systemic Amyloidosis Due to Mutation in Zdhhc13, a Gene Coding for Palmitoyl Acyltransferase
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- The changing landscape of managing hair loss: a 30‐year perspective
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- AGA practitioner challenges: A mixed‐methods pilot survey
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Role of trichoscopy in diagnosis of different hair and scalp disorders in pediatrics
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- Serum Zinc Concentration in Patients with Alopecia Areata
- Study of the international epidemiology of androgenetic alopecia in young caucasian men using photographs from the internet
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata